Even more prominently, inactivation of the distal FA pathway through mutations in the BRCA2 (FANCD1) gene has been reported in breast cancer [14] (familial cases [15–17]), pancreatic cancer [18, 19] and ovarian cancer [20], among others. This evidence concerns the gene BRCA2 and ovarian cancer.